Exercise Capacity

Riociguat treatment significantly improved exercise capacity and prevented clinical worsening in patients with sarcoidosis-associated pulmonary hypertension, according to study results published in Chest.

Among adults born at very low birth weight, exercise capacity was significantly reduced compared with those who were term born, according to findings published in the American Journal of Respiratory and Critical Care Medicine.

Among veterans with COPD, pain was highly prevalent and was significantly associated with lower exercise capacity, according to findings published in BMC Pulmonary Medicine.

A cohort of young adults born small for gestational age demonstrated marked reductions in exercise capacity compared with a control group in a new study.

In a preliminary analysis of the ongoing SPECTRA study, patients with pulmonary arterial hypertension treated with sotatercept had improvements in hemodynamics, exercise capacity and 6-minute walk distance.

Patients with COPD who completed an 8-week pulmonary rehabilitation program had sustained improvements in anxiety and quality of life at 2-year follow-up, according to findings published in Chest.

Compared with moderate training, high-intensity interval training yielded no significant difference in peak oxygen consumption after 3 months in patients with HF with preserved ejection fraction, researchers reported.

The loss of estrogen’s protective role in exercise capacity could contribute to the gender gap in overall health between men and women with cystic fibrosis, a presenter at the North American Cystic Fibrosis Conference suggested.

Among people with type 2 diabetes, those with increased exercise capacity had a significantly decreased risk for all-cause mortality, according to data presented at the virtual European Association for the Study of Diabetes annual meeting.

Adults with ventricular septal defects had poorer exercise capacity compared with adults without them, researchers found.